Annual Report And Accounts

Overview

The report presents hVIVO as a world leader in human challenge trials, with 2022 revenue of £50.7m and EBITDA of £9.1m. The Group delivered seven challenge trials, expanded FluCamp screening facilities and inoculated 413 volunteers across its 2022 projects. It also established an ESG Group reporting to the Audit and Risk Committee and disclosed combined Scope 1, 2 and 3 emissions of 104.3 tCO2e.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services